Leverage Shares 2X Long OSCR Daily ETF
OSCG
NASDAQ- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Leverage Shares 2X Long OSCR Daily ETF (OSCG) is an actively managed exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times (200%) the daily percentage change in the price of Oscar Health, Inc. (NYSE: OSCR) common stock, a healthcare technology company focused on health insurance plans; the fund employs swap agreements, cash equivalents, and other financial instruments to achieve its leveraged exposure, with holdings typically including swaps with counterparties such as Cantor, Marex, and Credit Suisse, alongside minimal cash positions for collateral and daily rebalancing. OSCG trades on the Nasdaq exchange under the ticker OSCG with CUSIP 88340C784 and ISIN US88340C7847, features a total expense ratio of 0.75%, and exhibits a 30-day median bid/ask spread of 0.51%; it provides 2x leveraged exposure to the healthcare sector and the United States market without the need for margin accounts or exposure to margin calls, capping investor losses at the invested principal amount. Launched on November 5, 2025, OSCG represents a recent expansion in Leverage Shares' lineup of single-stock daily leveraged ETFs, issued through the Themes ETF Trust and managed by Leverage Shares, a provider founded in 2017 with headquarters in Greenwich, Connecticut, that pioneered single-stock exchange-traded products (ETPs) in Europe and now operates a suite of over 160 leveraged and unleveraged ETPs and ETFs listed across U.S., European, and other exchanges. In the past year, Leverage Shares has pursued aggressive product diversification as its primary strategic shift, launching 19 new ETPs on the London Stock Exchange in September 2025 including the first 3x leveraged products on stocks such as Robinhood (HOOD), Hims & Hers (HIMS), and UnitedHealth (UNH); expanding its U.S. single-stock leveraged ETF offerings in November 2025 with products tracking NU, NET, OKTA, TER, NEM, CMG, ABNB, SPOT, and SBUX; and introducing additional 2x long daily ETFs in December 2025 such as those on IREN, BE, GEV, and SATS under the "Leverage Shares by Themes" branding.